Literature DB >> 9150739

Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene.

J Maynard1, M Krawczak, M Upadhyaya.   

Abstract

Nine novel mutations have been characterized as the result of screening exon 16 of the human NF1 gene in 465 unrelated neurofibromatosis type 1 patients. These lesions include three nonsense and two missense mutations, two deletions, one duplication, and one mutation in the 5' splice site of intron 16. Although exon 16 is the largest NF1 exon, no mutations have so far been reported in this region. This apparent paucity of lesions may be due either to a reduced functional importance of exon 16 or a screening bias or both. However, consideration of the mutability of exon 16 in comparison with other exons suggests that, at least for single base pair substitutions, no such factors need be invoked. Any previous lack of exon 16 mutations in this category would be explicable in terms of a lower propensity to mutate for codons in this gene region.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150739     DOI: 10.1007/s004390050427

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  A search for evidence of somatic mutations in the NF1 gene.

Authors:  A M John; M Ruggieri; R Ferner; M Upadhyaya
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

2.  Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas.

Authors:  Laura Thomas; Gill Spurlock; Claire Eudall; Nick S Thomas; Matthew Mort; Stephen E Hamby; Nadia Chuzhanova; Hilde Brems; Eric Legius; David N Cooper; Meena Upadhyaya
Journal:  Eur J Hum Genet       Date:  2011-11-23       Impact factor: 4.246

3.  Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.

Authors:  R Fahsold; S Hoffmeyer; C Mischung; C Gille; C Ehlers; N Kücükceylan; M Abdel-Nour; A Gewies; H Peters; D Kaufmann; A Buske; S Tinschert; P Nürnberg
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

4.  Mutation screening in a Norwegian cohort with pheochromocytoma.

Authors:  Wenche Sjursen; Henrik Halvorsen; Eva Hofsli; Siri Bachke; Asa Berge; Lars F Engebretsen; Sture E Falkmer; Ursula G Falkmer; Jan E Varhaug
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

5.  Genetic Analyses of the NF1 Gene in Turkish Neurofibromatosis Type I Patients and Definition of three Novel Variants.

Authors:  S D Ulusal; H Gürkan; E Atlı; S A Özal; M Çiftdemir; H Tozkır; Y Karal; H Güçlü; D Eker; I Görker
Journal:  Balkan J Med Genet       Date:  2017-06-30       Impact factor: 0.519

6.  The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1.

Authors:  Seon-Yong Jeong; Sang-Jin Park; Hyon J Kim
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

7.  Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1.

Authors:  Nahla N Abdel-Aziz; Ghada Y El-Kamah; Rabab A Khairat; Hanan R Mohamed; Yehia Z Gad; Akmal M El-Ghor; Khalda S Amr
Journal:  Mol Genet Genomic Med       Date:  2021-06-03       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.